In the present study, a novel transcription factor, CHREBP, was assessed to determine its role in GC, and it was revealed that CHREBP suppresses GC progression by promoting cell apoptosis and inhibiting the cell cycle, thereby affecting tumor proliferation, and that it could serve as a significant prognostic biomarker. This evidence concerns the gene MLXIPL and neoplasm.